Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Authors
Santamaria, Manuel
Neth, Olaf
Douglass, Jo A
Krivan, Gergely
Kobbe, Robin
Bernatowska, Ewa
Grigoriadou, Sofia
Bethune, Claire
Chandra, Anita
Horneff, Gerd
Borte, Michael
Sonnenschein, Anja
Kralickova, Pavlina
Ramón, Silvia Sánchez
Langguth, Daman D
Gonzalez-Granado, Luis Ignacio
Querolt, Montse
Griffin, Rhonda
Hames, Carrie
Mondou, Elsa
Price, Jeffrey
Sanz, Ana
Lin, Jiang
Publication Date
2022-04Journal Title
J Clin Immunol
ISSN
0271-9142
Publisher
Springer Science and Business Media LLC
Volume
42
Issue
3
Pages
512-513
Language
en
Type
Other
This Version
VoR
Metadata
Show full item recordCitation
Santamaria, M., Neth, O., Douglass, J. A., Krivan, G., Kobbe, R., Bernatowska, E., Grigoriadou, S., et al. (2022). Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.. [Other]. https://doi.org/10.1007/s10875-022-01219-3
Keywords
Correction
Identifiers
s10875-022-01219-3, 1219
External DOI: https://doi.org/10.1007/s10875-022-01219-3
This record's DOI: https://doi.org/10.17863/CAM.83632
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.